Latest Headlines

31. Illumina And Myriad Genetics Expand Partnership To Broaden Access To HRD Testing In The United States 3/2/2023

    Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous recombination deficiency (HRD) testing in the United States. 

32. Synergy Laboratories Taps SOPHiA GENETICS Technology For New Cancer Profiling Solution 2/28/2023

    SOPHiA GENETICS, a cloud-native software company in the healthcare space, today announced that Synergy Oncology, part of Synergy Laboratories, a full-service diagnostic laboratory based in Mobile, Alabama, will use SOPHiA DDM to develop a new cancer profiling solution

33. Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test For Early Detection Of Coronary Heart Disease 2/28/2023

    Cardio Diagnostics Holdings Inc, an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

34. Roche Joins Forces With The U.S. Centers For Disease Control And Prevention To Strengthen Laboratory Systems In The Fight Against The HIV And Tuberculosis Epidemics 2/28/2023
35. Azenta Launches Cryo Store Pico™, A Novel Automated Cryogenic Storage System Designed For Clinical And Laboratory Applications 2/27/2023

    Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the Cryo Store Pico™ ("Pico"), a novel automated cryogenic storage system designed for high-value biological samples used in the many stages of life sciences, from discovery to clinical use

36. Clarapath Acquires Crosscope And Combines Tissue Processing Robotics With AI Powered Digital Pathology For Building The Lab Of The Future 2/27/2023

    Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue, today announced the acquisition of Mountain View, CA-based Crosscope

37. Lucira Health Announces FDA Authorization Of First & Only At-Home Combination Covid-19 & Flu Test And Comments On Chapter 11 Bankruptcy Filing 2/27/2023

    Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for its Lucira COVID-19 & Flu Home Test for over the counter (OTC) use at home and other non-laboratory sites

38. PerkinElmer Launches EnVison Nexus Multimode Plate Reader To Drive Improved Research And Discovery Workflows 2/24/2023

    PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the EnVision Nexus system, its fastest and most sensitive multimode plate reader to date, designed for demanding high-throughput screening (HTS) applications and to accelerate drug discovery efforts.

39. Chembio Announces The Receipt Of CLIA Waiver For Its DPP HIV-Syphilis System 2/24/2023

    Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the DPP HIV-Syphilis System.

40. Malaysian Genomics To Offer World's First DNA-Driven Fertility Test 2/23/2023

    Malaysian Genomics Resource Centre Bhd [MGRC], a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a strategic collaboration agreement with Divine Genes Sdn Bhd to collaborate on business opportunities in relation to the improvement and international distribution of genetic tests for reproductive health